Immunosuppressive drug measurement by liquid chromatography coupled to tandem mass spectrometry: Interlaboratory comparison in the Korean clinical laboratories

on behalf of the Clinical Mass Spectrometry Research Committee of the Korean Society of Clinical Chemistry

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) is increasingly used for immunosuppressive drug tests. However, most LC-MS/MS tests are laboratory-developed and their agreement is unknown in different Korean laboratories. This interlaboratory comparison study evaluated test reproducibility and identified potential error sources. Methods: Test samples containing three concentrations of tacrolimus, sirolimus, everolimus, cyclosporine, and mycophenolic acid were prepared by pooling surplus samples from patients undergoing routine therapeutic drug monitoring and tested in duplicate in the participating 10 clinical laboratories. Reconstitution and storage experiments were conducted for the commonly used commercial calibrator set. The robust estimators of reproducibility parameters were calculated. Spearman’s rank correlation coefficient (rho, ρ) was used to evaluate the correlation between drugs. Multiple linear regression was used to determine whether the experimental conditions alter the calibration curves. Results: The reproducibility coefficient of variation exceeded 10% only for sirolimus concentrations 1 and 2 (10.8% and 12.5%, respectively) and everolimus concentrations 1 and 2 (12.3% and 11.4%, respectively). The percent difference values showed weak correlations between sirolimus and everolimus (ρ = 0.334, P = 0.175). The everolimus calibration curve slope was significantly altered after reconstitution following prolonged 5°C storage (P = 0.015 for 14 days; P = 0.025 for 28 days); the expected differences at 6 ng/mL were 0.598% for 14 days and 0.384% for 28 days. Conclusions: LC-MS/MS test reproducibility for immunosuppressive drugs seems to be good in the Korean clinical laboratories. Continuous efforts are required to achieve test standardization and harmonization, especially for sirolimus and everolimus.

Original languageEnglish
Pages (from-to)268-276
Number of pages9
JournalAnnals of laboratory medicine
Volume41
Issue number3
DOIs
StatePublished - May 2021

Keywords

  • Everolimus
  • Immunosuppressive drug
  • Interlaboratory comparison
  • Liquid chromatography coupled to tandem mass spectrometry
  • Reproducibility
  • Sirolimus
  • Therapeutic drug monitoring

Fingerprint Dive into the research topics of 'Immunosuppressive drug measurement by liquid chromatography coupled to tandem mass spectrometry: Interlaboratory comparison in the Korean clinical laboratories'. Together they form a unique fingerprint.

Cite this